These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31537382)

  • 21. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues.
    Arai S; Miyashiro Y; Shibata Y; Tomaru Y; Kobayashi M; Honma S; Suzuki K
    Steroids; 2011 Feb; 76(3):301-8. PubMed ID: 21147140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.
    Yang ES; Maiorino CA; Roos BA; Knight SR; Burnstein KL
    Mol Cell Endocrinol; 2002 Jan; 186(1):69-79. PubMed ID: 11850123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy.
    Filon MJ; Gillette AA; Yang B; Khemees TA; Skala MC; Jarrard DF
    Prostate; 2022 Dec; 82(16):1547-1557. PubMed ID: 35980831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pomegranate extracts impact the androgen biosynthesis pathways in prostate cancer models in vitro and in vivo.
    Ming DS; Pham S; Deb S; Chin MY; Kharmate G; Adomat H; Beheshti EH; Locke J; Guns ET
    J Steroid Biochem Mol Biol; 2014 Sep; 143():19-28. PubMed ID: 24565566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconsideration of progression to CRPC during androgen deprivation therapy.
    Mizokami A; Namiki M
    J Steroid Biochem Mol Biol; 2015 Jan; 145():164-71. PubMed ID: 24717975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer.
    Klein H; Bressel M; Kastendieck H; Voigt KD
    Am J Clin Oncol; 1988; 11 Suppl 2():S30-6. PubMed ID: 2853935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal steroids in human prostatic cancer cell lines.
    Koh E; Kanaya J; Namiki M
    Arch Androl; 2001; 46(2):117-25. PubMed ID: 11297065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells.
    Rizner TL; Lin HK; Penning TM
    Chem Biol Interact; 2003 Feb; 143-144():401-9. PubMed ID: 12604227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
    Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
    Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.
    Lundqvist J; Norlin M; Wikvall K
    Biochim Biophys Acta; 2011 Apr; 1811(4):263-70. PubMed ID: 21262387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracrine androgen biosynthesis, metabolism and action revisited.
    Schiffer L; Arlt W; Storbeck KH
    Mol Cell Endocrinol; 2018 Apr; 465():4-26. PubMed ID: 28865807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex steroid hormone metabolism and prostate cancer.
    Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal therapy of prostate cancer.
    Labrie F
    Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells.
    Martin JL; Pattison SL
    Endocrinology; 2000 Jul; 141(7):2401-9. PubMed ID: 10875240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies on androgen suppression in therapy of prostate carcinoma.
    Sandow J; von Rechenberg W; Engelbart K
    Am J Clin Oncol; 1988; 11 Suppl 1():S6-10. PubMed ID: 3291602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
    Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
    Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.